A leading multidisciplinary forum for the global immuno-oncology community, this international meeting will bring together researchers, clinicians and other stakeholders to expand the frontiers of immuno-oncology through advanced therapies, with a strong focus on addressing the current scientific and clinical barriers to effective cancer immunotherapy.

Covering the full spectrum from basic science to translational research and clinical development, the congress will highlight evolving immuno‑oncology approaches and advanced therapeutic strategies, reflecting the dynamic progress of the field across multiple areas of investigation.

Emerging technologies and new biological insights will be central to the scientific exchange, shaping a deeper understanding of tumour–immune interactions and supporting more precise, effective and safe applications of immunotherapy. Discussions will span key challenges and opportunities in the field, including treatment resistance, safety considerations, tumour complexity and the translation of research advances into clinical practice.

Join the global immuno-oncology community to learn, share your expertise and engage with peers committed to advancing cancer care through innovation, collaboration and scientifically grounded progress.